Health News Releases

  • Today May 19
June 20, 2017 17:30
New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherland
June 19, 2017 22:00
First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden
Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk fac
June 19, 2017 16:45
Herbalife Nutrition Encourages North Asia Members to Play a Bigger Role in Inspiring Healthy Active Living in Their Local Communities
Global nutrition company, Herbalife (NYSE:HLF), has concluded its annual Asia Pacific Extravaganza for North Asia, held from June 16 to 18 in Hong Kong. As a training event organized for Herbalife Nut
June 16, 2017 13:55
Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium (Paris)
Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium proudly announces today that Merck, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, be
June 15, 2017 12:10
SERMO Announces Massive Global Expansion, Now Available in More Than 150 Countries
SERMO - the largest global social network for physicians that is revolutionizing medical crowdsourcing - today furthered its goal of uniting doctors worldwide by expanding to more than 150 countries.
June 15, 2017 11:35
Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®
Boehringer Ingelheim announced today results from the pivotal Phase III VOLTAIRE®-RA[1] study, confirming that its adalimumab biosimilar candidate BI 695501 and HUMIRA®* have similar efficacy, safety
June 15, 2017 11:25
Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced results from the phase 2a SLE-001 trial evaluating CC-220, the Company's investigational, or
June 15, 2017 11:15
Pimodivir Alone or in Combination with Oseltamivir Demonstrated a Significant Reduction in Viral Load in Adults with Influenza A
Janssen Pharmaceuticals, Inc. (Janssen) today announced results from the Phase 2b Topaz Trial which demonstrated that treatment with pimodivir (JNJ-63623872) significantly decreased viral load over se
June 13, 2017 11:55
Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
GE Chairman and CEO Jeff Immelt announced today the appointment of Kieran Murphy as president and CEO of GE Healthcare, effective immediately. Murphy is currently president and CEO of GE Healthcare Li
June 13, 2017 11:15
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the recent International Anesthesia Research Society (IARS) Annual Meeting in Washington, DC. In the study, researchers a
June 08, 2017 18:55
Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the randomized Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab
June 08, 2017 16:45
Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation
Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced new efficacy and safety data from the ongoing Phase 1 dose-escalation and expansion study evaluating inv
June 08, 2017 10:40
22nd Century Produces Non-GMO Very Low Nicotine Tobacco
22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that the Company’s research collaboration with
June 07, 2017 18:30
Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter® with Next Generation SpHb®
Masimo (NASDAQ:MASI) announced today, in conjunction with its CE marking, the limited market release of the Spot-Check Rad-67™ Handheld Pulse CO-Oximeter®. Rad-67 offers Measure-through Motion and Low
June 07, 2017 18:00
Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.
Claret Medical® today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Sentinel™ Cerebral Protection System (CPS), via de novo classificatio
June 07, 2017 11:42
The world’s first genome-based sharing platform ‘MyGenomeBox,’ to Showcase New Revolution and Life Experience on DNA App Store at CES Asia 2017
MyGenomeBox, the world’s first open genome-based sharing platform, will participate in “CES Asia 2017” to introduce their service in Asian market. CES Asia 2017 will be held from June 7 to 9 at the
June 07, 2017 10:55
AstraZeneca Presents Tagrisso(osimertinib) Data in Patients with EGFR T790M-Mutation Positive Lung Cancer and Central Nervous System Metastases
AstraZeneca today reported further evidence that Tagrisso (osimertinib), the potential new standard of care for adult patients with locally advanced or metastatic epidermal growth factor receptor (EGF
June 05, 2017 18:00
Encouraging Phase II survival data for nintedanib in malignant pleural mesothelioma presented at ASCO 2017
Boehringer Ingelheim today announced that Phase II results from LUME-Meso, a randomised, double-blind, placebo-controlled trial, have been presented as part of an Oral Abstract Session at the 2017 Ann
June 05, 2017 11:30
Masimo and Mdoloris Announce Masimo Open Connect™ (MOC) Partnership for the Root® Patient Monitoring and Connectivity Hub
Masimo (NASDAQ: MASI) and Mdoloris Medical Systems announced today a Masimo Open Connect™ (MOC) partnership for the Root® Open Architecture Patient Monitoring and Connectivity Hub, in which Mdoloris i
June 02, 2017 15:35
Lynparza (olaparib) Maintenance Treatment Offers Sustained Quality of Life alongside Improved Progression-Free Survival in Women with BRCA-Mutated Ovarian Cancer
AstraZeneca today reported new data from the Phase III SOLO-2 trial of Lynparza (olaparib) 300mg twice-daily tablet maintenance treatment showing that quality of life (QoL) is sustained alongside impr
June 02, 2017 11:45
Ferring Appoints Aaron Graff to Executive Board
Ferring Pharmaceuticals announced today that Aaron Graff has been appointed Executive Vice President and Chief Commercial Officer and made a member of the Ferring Group Executive Board, effective imme
June 01, 2017 13:50
Chiltern Acquires Japanese Clinical Research Organization Integrated Development Associates Co. Ltd.
Chiltern, a leading global contract research organization, has acquired Integrated Development Associates Co. Ltd. (IDA), a CRO specializing in integrating Japan and Asia into global drug development.
June 01, 2017 13:35
Boston Healthcare Associates and Data Information Intelligence Announce Global Life Sciences Data Commercialization Partnership
Boston Healthcare Associates, Inc. (Boston Healthcare), a global life sciences consultancy, and Data Information Intelligence GmbH (dii) today announced a new partnership to develop and commercialize
May 30, 2017 16:35
Takeda Showcases Broadened Oncology Portfolio Through Data Presentations at Upcoming Medical Meetings
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature new clinical analyses and outcomes research during three upcoming medical meetings: the 53rd Annual Meet
May 30, 2017 13:30
World Bedwetting Day Steering Committee: New global guidelines call for more effective treatment for bedwetting, a common condition which affects 1 in 15 children[1]
The World Bedwetting Day Steering Committee (WBD-SC) has launched simplified practical guidelines to help healthcare professionals understand how best to treat bedwetting. “For decades, people thou
25 per page50 per page75 per page100 per page